Medicus Pharma Ltd. - Common shares, no par value (MDCX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2024 to Q4 2025

Type / Class
Equity / Common shares, no par value
Symbol
MDCX on Nasdaq
Shares outstanding
25,378,604
Price per share
$1.25
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
3,939,093
Total reported value
$6,026,447
% of total 13F portfolios
0%
Share change
+1,819,626
Value change
+$2,578,454
Number of holders
20
Price from insider filings
$1.25
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Medicus Pharma Ltd. - Common shares, no par value (MDCX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Melani Kenneth R. 18% -35% $9,843,685 -$227,250 3,248,741 -2.3% Melani Kenneth R. 30 Jun 2025
Raju Ajay 17% $8,120,000 2,000,000 Ajay Raju 31 Dec 2024
Bokhari Raza 4.8% -46% $2,375,437 +$316,875 1,218,173 +15% Bokhari Raza 31 Dec 2025
ARMISTICE CAPITAL, LLC 5% -49% $2,835,244 -$1,000,736 935,724 -26% Armistice Capital, LLC 30 Jun 2025
Hathaway John Jason 4.5% -33% $2,426,885 800,952 0% John Hathaway 30 Jun 2025

As of 31 Dec 2025, 20 institutional investors reported holding 3,939,093 shares of Medicus Pharma Ltd. - Common shares, no par value (MDCX). This represents 16% of the company’s total 25,378,604 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Medicus Pharma Ltd. - Common shares, no par value (MDCX) together control 16% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ARMISTICE CAPITAL, LLC 7.1% 1,810,960 0.07% $2,770,769
Interchange Capital Partners, LLC 6.3% 1,586,871 0% 0.45% $2,427,912
Private Advisor Group, LLC 0.69% 175,495 +16% 0% $268,507
JANE STREET GROUP, LLC 0.24% 60,337 0% $92,316
Wilmington Savings Fund Society, FSB 0.2% 51,244 +100% 0% $78,403
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.16% 40,162 0% $61,448
May Hill Capital, LLC 0.14% 35,622 +100% 0.01% $54,502
BlackRock, Inc. 0.14% 34,317 +112% 0% $52,505
COMMONWEALTH EQUITY SERVICES, LLC 0.11% 28,493 +162% 0% $43,590
HRT FINANCIAL LP 0.11% 27,529 0% $42,000
BRAVE ASSET MANAGEMENT INC 0.08% 20,000 0% 0.01% $30,600
MORGAN STANLEY 0.07% 18,306 +207% 0% $28,008
Smithfield Trust Co 0.05% 13,883 0% $21,000
UBS Group AG 0.05% 13,231 +90% 0% $20,243
TWO SIGMA INVESTMENTS, LP 0.05% 12,319 0% $18,848
OSAIC HOLDINGS, INC. 0.03% 8,500 -39% 0% $13,005
Larson Financial Group LLC 0% 1,000 0% 0% $1,530
JONES FINANCIAL COMPANIES LLLP 0% 400 0% 0% $612
DAGCO, INC. 0% 349 0% 0% $534
WELLS FARGO & COMPANY/MN 0% 75 0% 0% $115
Base Wealth Management LLC 0% 0 -100% $0
Yorkville Advisors Global, LP 0% 0 -100% $0
CITIGROUP INC 0% 0 -100% $0
FNY Investment Advisers, LLC 0% 0 -100% $0
LPL Financial LLC 0% 0 -100% $0

Institutional Holders of Medicus Pharma Ltd. - Common shares, no par value (MDCX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 3,939,093 $6,026,447 +$2,578,454 $1.53 20
2025 Q3 2,119,467 $4,905,211 -$365,331 $2.32 20
2025 Q2 2,206,052 $6,595,875 -$3,790,457 $2.99 21
2025 Q1 3,051,629 $11,352,061 +$5,738,203 $3.72 7
2024 Q4 1,503,368 $3,741,062 +$3,741,062 $2.46 3